Banks - Regional
Build Your Comparison
Side-by-side financial analysisStock Comparison
VABK vs MNSB vs NBTB vs CARE vs FIS
Revenue, margins, valuation, and 5-year total return — side by side.
Banks - Regional
Banks - Regional
Banks - Regional
Information Technology Services
VABK vs MNSB vs NBTB vs CARE vs FIS — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Banks - Regional | Banks - Regional | Banks - Regional | Banks - Regional | Information Technology Services |
| Market Cap | $244M | $184M | $2.52B | $662M | $20.26B |
| Revenue (TTM) | $83M | $135M | $902M | $252M | $11.66B |
| Net Income (TTM) | $19M | $16M | $169M | $31M | $2.67B |
| Gross Margin | 69.0% | 54.3% | 73.6% | 61.2% | 37.6% |
| Operating Margin | 28.9% | 14.1% | 24.3% | 15.9% | 17.9% |
| Forward P/E | 12.7x | 11.0x | 11.5x | 5.5x | 6.2x |
| Total Debt | $30M | $70M | $327M | $179M | $4.01B |
| Cash & Equiv. | $6M | $26M | $185M | $105M | $599M |
VABK vs MNSB vs NBTB vs CARE vs FIS — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jun 20 | Jun 26 | Return |
|---|---|---|---|
| Virginia National B… (VABK) | 100 | 178.2 | +78.2% |
| MainStreet Bancshar… (MNSB) | 100 | 188.9 | +88.9% |
| NBT Bancorp Inc. (NBTB) | 100 | 156.6 | +56.6% |
| Carter Bankshares, … (CARE) | 100 | 370.2 | +270.2% |
| Fidelity National I… (FIS) | 100 | 29.2 | -70.8% |
Price return only. Dividends and distributions are not included.
Quick Verdict: VABK vs MNSB vs NBTB vs CARE vs FIS
Each card shows where this stock fits in a portfolio — not just who wins on paper.
VABK has the current edge in this matchup, primarily because of its strength in income & stability and long-term compounding.
- Dividend streak 1 yrs, beta 0.48, yield 3.1%
- 146.5% 10Y total return vs CARE's 141.7%
- Lower volatility, beta 0.48, Low D/E 16.2%, current ratio 3.53x
- Beta 0.48, yield 3.1%, current ratio 3.53x
MNSB is the clearest fit if your priority is bank quality.
- NIM 3.1% vs CARE's 2.7%
NBTB is the #2 pick in this set and the best alternative if growth and dividends is your priority.
- 10.4% NII/revenue growth vs MNSB's -1.4%
- 3.0% yield, 13-year raise streak, vs FIS's 4.2%, (1 stock pays no dividend)
CARE is the clearest fit if your priority is growth exposure.
- Rev growth 6.2%, EPS growth 32.1%
- +79.6% vs FIS's -49.4%
FIS ranks third and is worth considering specifically for valuation efficiency.
- PEG 0.26 vs VABK's 3.36
- Lower P/E (6.2x vs 11.5x), PEG 0.26 vs 1.64
- 7.5% ROA vs CARE's 0.7%, ROIC 6.0% vs 5.7%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 10.4% NII/revenue growth vs MNSB's -1.4% | |
| Value | Lower P/E (6.2x vs 11.5x), PEG 0.26 vs 1.64 | |
| Quality / Margins | 23.1% margin vs MNSB's 11.5% | |
| Stability / Safety | Beta 0.48 vs NBTB's 0.76, lower leverage | |
| Dividends | 3.0% yield, 13-year raise streak, vs FIS's 4.2%, (1 stock pays no dividend) | |
| Momentum (1Y) | +79.6% vs FIS's -49.4% | |
| Efficiency (ROA) | 7.5% ROA vs CARE's 0.7%, ROIC 6.0% vs 5.7% |
VABK vs MNSB vs NBTB vs CARE vs FIS — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
VABK vs MNSB vs NBTB vs CARE vs FIS — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
VABK leads in 1 of 6 categories
CARE leads 1 • MNSB leads 0 • NBTB leads 0 • FIS leads 0 • 4 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
VABK leads this category, winning 3 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
FIS is the larger business by revenue, generating $11.7B annually — 139.9x VABK's $83M. VABK is the more profitable business, keeping 23.1% of every revenue dollar as net income compared to MNSB's 11.5%.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $83M | $135M | $902M | $252M | $11.7B |
| EBITDAEarnings before interest/tax | $26M | $23M | $241M | $46M | $4.1B |
| Net IncomeAfter-tax profit | $19M | $16M | $169M | $31M | $2.7B |
| Free Cash FlowCash after capex | $21M | $11M | $225M | $30M | $2.8B |
| Gross MarginGross profit ÷ Revenue | +69.0% | +54.3% | +73.6% | +61.2% | +37.6% |
| Operating MarginEBIT ÷ Revenue | +28.9% | +14.1% | +24.3% | +15.9% | +17.9% |
| Net MarginNet income ÷ Revenue | +23.1% | +11.5% | +18.8% | +12.5% | +22.9% |
| FCF MarginFCF ÷ Revenue | +24.9% | +7.9% | +24.9% | +11.9% | +23.9% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — | — | — | +30.1% |
| EPS Growth (YoY)Latest quarter vs prior year | +31.0% | +120.9% | +39.5% | +8.3% | +30.6% |
Valuation Metrics
Evenly matched — MNSB and FIS each lead in 2 of 7 comparable metrics.
Valuation Metrics
At 12.7x trailing earnings, VABK trades at a 76% valuation discount to FIS's 52.3x P/E. Adjusting for growth (PEG ratio), NBTB offers better value at 2.06x vs VABK's 3.36x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $244M | $184M | $2.5B | $662M | $20.3B |
| Enterprise ValueMkt cap + debt − cash | $268M | $227M | $2.7B | $735M | $23.7B |
| Trailing P/EPrice ÷ TTM EPS | 12.68x | 14.16x | 14.47x | 21.34x | 52.27x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 11.03x | 11.54x | 5.47x | 6.24x |
| PEG RatioP/E ÷ EPS growth rate | 3.36x | — | 2.06x | — | 2.14x |
| EV / EBITDAEnterprise value multiple | 11.13x | 11.90x | 11.03x | 18.38x | 6.50x |
| Price / SalesMarket cap ÷ Revenue | 2.93x | 1.35x | 2.90x | 2.60x | 1.90x |
| Price / BookPrice ÷ Book value/share | 1.32x | 0.87x | 1.29x | 1.60x | 1.46x |
| Price / FCFMarket cap ÷ FCF | 11.76x | 17.26x | 11.49x | 20.81x | 7.21x |
Profitability & Efficiency
Evenly matched — VABK and FIS each lead in 4 of 9 comparable metrics.
Profitability & Efficiency
FIS delivers a 18.4% return on equity — every $100 of shareholder capital generates $18 in annual profit, vs $7 for MNSB. VABK carries lower financial leverage with a 0.16x debt-to-equity ratio, signaling a more conservative balance sheet compared to CARE's 0.43x. On the Piotroski fundamental quality scale (0–9), CARE scores 8/9 vs MNSB's 5/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +11.0% | +7.3% | +9.5% | +7.6% | +18.4% |
| ROA (TTM)Return on assets | +1.2% | +0.7% | +1.1% | +0.7% | +7.5% |
| ROICReturn on invested capital | +9.0% | +5.0% | +7.9% | +5.7% | +6.0% |
| ROCEReturn on capital employed | +2.6% | +6.0% | +2.4% | +1.5% | +6.6% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 5 | 7 | 8 | 6 |
| Debt / EquityFinancial leverage | 0.16x | 0.32x | 0.17x | 0.43x | 0.29x |
| Net DebtTotal debt minus cash | $24M | $43M | $142M | $73M | $3.4B |
| Cash & Equiv.Liquid assets | $6M | $26M | $185M | $105M | $599M |
| Total DebtShort + long-term debt | $30M | $70M | $327M | $179M | $4.0B |
| Interest CoverageEBIT ÷ Interest expense | 0.94x | 0.31x | 1.05x | 0.39x | 21.16x |
Total Returns (Dividends Reinvested)
CARE leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CARE five years ago would be worth $20,802 today (with dividends reinvested), compared to $3,267 for FIS. Over the past 12 months, CARE leads with a +79.6% total return vs FIS's -49.4%. The 3-year compound annual growth rate (CAGR) favors CARE at 24.7% vs FIS's -6.8% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +15.2% | +26.5% | +17.6% | +54.3% | -38.9% |
| 1-Year ReturnPast 12 months | +24.1% | +37.2% | +18.3% | +79.6% | -49.4% |
| 3-Year ReturnCumulative with dividends | +61.9% | +13.1% | +48.5% | +93.9% | -18.9% |
| 5-Year ReturnCumulative with dividends | +50.9% | +18.1% | +44.4% | +108.0% | -67.3% |
| 10-Year ReturnCumulative with dividends | +146.5% | +135.4% | +108.5% | +141.7% | -25.6% |
| CAGR (3Y)Annualised 3-year return | +17.4% | +4.2% | +14.1% | +24.7% | -6.8% |
Risk & Volatility
Evenly matched — VABK and NBTB each lead in 1 of 2 comparable metrics.
Risk & Volatility
VABK is the less volatile stock with a 0.48 beta — it tends to amplify market swings less than NBTB's 0.76 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. NBTB currently trades 99.8% from its 52-week high vs FIS's 47.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.48x | 0.60x | 0.76x | 0.58x | 0.61x |
| 52-Week HighHighest price in past year | $48.58 | $25.17 | $48.27 | $29.99 | $82.74 |
| 52-Week LowLowest price in past year | $36.48 | $17.86 | $39.20 | $16.14 | $37.91 |
| % of 52W HighCurrent price vs 52-week peak | +92.6% | +99.0% | +99.8% | +99.6% | +47.4% |
| RSI (14)Momentum oscillator 0–100 | 63.0 | 65.3 | 63.1 | 72.8 | 30.8 |
| Avg Volume (50D)Average daily shares traded | 6K | 45K | 266K | 316K | 5.6M |
Analyst Outlook
Evenly matched — NBTB and FIS each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: MNSB as "Hold", NBTB as "Hold", CARE as "Hold", FIS as "Buy". Consensus price targets imply 60.4% upside for FIS (target: $63) vs -4.6% for CARE (target: $29). For income investors, FIS offers the higher dividend yield at 4.16% vs MNSB's 1.60%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Hold | Hold | Hold | Buy |
| Price TargetConsensus 12-month target | — | — | $46.00 | $28.50 | $62.88 |
| # AnalystsCovering analysts | — | 1 | 10 | 5 | 37 |
| Dividend YieldAnnual dividend ÷ price | +3.1% | +1.6% | +3.0% | — | +4.2% |
| Dividend StreakConsecutive years of raises | 1 | 0 | 13 | 0 | 1 |
| Dividend / ShareAnnual DPS | $1.40 | $0.40 | $1.43 | — | $1.63 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +2.4% | +0.4% | +3.0% | +7.0% |
VABK leads in 1 of 6 categories (Income & Cash Flow). CARE leads in 1 (Total Returns). 4 tied.
VABK vs MNSB vs NBTB vs CARE vs FIS: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is VABK or MNSB or NBTB or CARE or FIS a better buy right now?
For growth investors, NBT Bancorp Inc.
(NBTB) is the stronger pick with 10. 4% revenue growth year-over-year, versus -1. 4% for MainStreet Bancshares, Inc. (MNSB). Virginia National Bankshares Corporation (VABK) offers the better valuation at 12. 7x trailing P/E, making it the more compelling value choice. Analysts rate Fidelity National Information Services, Inc. (FIS) a "Buy" — based on 37 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — VABK or MNSB or NBTB or CARE or FIS?
On trailing P/E, Virginia National Bankshares Corporation (VABK) is the cheapest at 12.
7x versus Fidelity National Information Services, Inc. at 52. 3x. On forward P/E, Carter Bankshares, Inc. is actually cheaper at 5. 5x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Fidelity National Information Services, Inc. wins at 0. 26x versus NBT Bancorp Inc. 's 1. 64x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — VABK or MNSB or NBTB or CARE or FIS?
Over the past 5 years, Carter Bankshares, Inc.
(CARE) delivered a total return of +108. 0%, compared to -67. 3% for Fidelity National Information Services, Inc. (FIS). Over 10 years, the gap is even starker: VABK returned +146. 5% versus FIS's -25. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — VABK or MNSB or NBTB or CARE or FIS?
By beta (market sensitivity over 5 years), Virginia National Bankshares Corporation (VABK) is the lower-risk stock at 0.
48β versus NBT Bancorp Inc. 's 0. 76β — meaning NBTB is approximately 59% more volatile than VABK relative to the S&P 500. On balance sheet safety, Virginia National Bankshares Corporation (VABK) carries a lower debt/equity ratio of 16% versus 43% for Carter Bankshares, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — VABK or MNSB or NBTB or CARE or FIS?
By revenue growth (latest reported year), NBT Bancorp Inc.
(NBTB) is pulling ahead at 10. 4% versus -1. 4% for MainStreet Bancshares, Inc. (MNSB). On earnings-per-share growth, the picture is similar: MainStreet Bancshares, Inc. grew EPS 210. 0% year-over-year, compared to -47. 2% for Fidelity National Information Services, Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — VABK or MNSB or NBTB or CARE or FIS?
Virginia National Bankshares Corporation (VABK) is the more profitable company, earning 23.
1% net margin versus 3. 6% for Fidelity National Information Services, Inc. — meaning it keeps 23. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: VABK leads at 28. 9% versus 14. 0% for MNSB. At the gross margin level — before operating expenses — NBTB leads at 72. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is VABK or MNSB or NBTB or CARE or FIS more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Fidelity National Information Services, Inc. (FIS) is the more undervalued stock at a PEG of 0. 26x versus NBT Bancorp Inc. 's 1. 64x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Carter Bankshares, Inc. (CARE) trades at 5. 5x forward P/E versus 11. 5x for NBT Bancorp Inc. — 6. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for FIS: 60. 4% to $62. 88.
08Which pays a better dividend — VABK or MNSB or NBTB or CARE or FIS?
In this comparison, FIS (4.
2% yield), VABK (3. 1% yield), NBTB (3. 0% yield), MNSB (1. 6% yield) pay a dividend. CARE does not pay a meaningful dividend and should not be held primarily for income.
09Is VABK or MNSB or NBTB or CARE or FIS better for a retirement portfolio?
For long-horizon retirement investors, Virginia National Bankshares Corporation (VABK) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
48), 3. 1% yield, +146. 5% 10Y return). Both have compounded well over 10 years (VABK: +146. 5%, CARE: +141. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between VABK and MNSB and NBTB and CARE and FIS?
These companies operate in different sectors (VABK (Financial Services) and MNSB (Financial Services) and NBTB (Financial Services) and CARE (Financial Services) and FIS (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: VABK is a small-cap deep-value stock; MNSB is a small-cap deep-value stock; NBTB is a small-cap deep-value stock; CARE is a small-cap quality compounder stock; FIS is a mid-cap income-oriented stock. VABK, MNSB, NBTB, FIS pay a dividend while CARE does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.